EUVIMEDEUVIMED entdecken
Crossref

Targeting immunogenic cell death for glioma immunotherapy

Tatiana A Mishchenko, Victoria D Turubanova, Ekaterina N Gorshkova, Olga Krysko, Maria V Vedunova, Dmitri V Krysko

Trends in Cancer · 2024-01 · 10 (1) · 8-11

DOI: 10.1016/j.trecan.2023.10.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Trends in Cancer, 2024-01. Verfasst von Tatiana A Mishchenko und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biology and Biomedicine, National Research Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod, Russia. Hauptthemen laut MEDLINE: Glioma, Antineoplastic Agents. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunogenic cell death (ICD) arouses great interest in targeting glioma, the most common primary brain tumor, to achieve boosted immunotherapy. We discuss the unexpected findings on the induction of Th17 immunity by ICD and propose the best design for dendritic cell (DC)-based vaccines loaded with whole glioma lysates obtained after ICD inducers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaAntineoplastic AgentsHumansImmunogenic Cell DeathImmunotherapy

Stichwörter der Autor:innen

DC vaccinesTh17cancerglioblastomatumor microenvironmentwhole tumor lysates

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Institute of Biology and Biomedicine, National Research Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod, Russia.
  • Institute of Biology and Biomedicine, National Research Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod, Russia; Neuroscience Research Institute, National Research Lobachevsky State University of Nizhny…
  • Cell Death Investigation and Therapy Laboratory, Anatomy and Embryology Unit, Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
  • Cell Death Investigation and Therapy Laboratory, Anatomy and Embryology Unit, Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium; Cancer Research Institut…

Förderung

  • Russian Science Foundation

Zitieren

APA

Mishchenko, T. A., Turubanova, V. D., Gorshkova, E. N., Krysko, O., Vedunova, M. V., & Krysko, D. V. (2024). Targeting immunogenic cell death for glioma immunotherapy. Trends in Cancer, 10(1), 8-11. https://doi.org/10.1016/j.trecan.2023.10.005

Vancouver

Mishchenko TA, Turubanova VD, Gorshkova EN, Krysko O, Vedunova MV, Krysko DV. Targeting immunogenic cell death for glioma immunotherapy. Trends in Cancer. 2024;10(1):8-11. doi:10.1016/j.trecan.2023.10.005

BibTeX
@article{Mishchenko2024,
  author = {Mishchenko, Tatiana A and Turubanova, Victoria D and Gorshkova, Ekaterina N and Krysko, Olga and Vedunova, Maria V and Krysko, Dmitri V},
  title = {Targeting immunogenic cell death for glioma immunotherapy},
  journal = {Trends in Cancer},
  year = {2024},
  volume = {10},
  number = {1},
  pages = {8--11},
  doi = {10.1016/j.trecan.2023.10.005}
}
Kostenlos starten →